Category: news
-
Despite Canadian government woes, neuroscience should win out
MONTREAL — When Canada’s Conservative government presented its 2011 budget in late March, the fiscal plan didn’t contain too many surprises for science funding. Like previous budgets, the proposal offered modest increases to the country’s national research agencies and replenished the coffers of Genome Canada, its genomics and proteomics outfit. But the budget also contained…
-
Canadian research shift makes waves
NRC Agency’s focus on industry-driven projects raises concerns that basic science will suffer. Published in Nature, 19 April 2011. Canada’s largest research entity has a new focus — and some disaffected scientists. On 1 April, the National Research Council (NRC), made up of more than 20 institutes and programmes with a total annual budget larger…
-
Why blog? Because it’s the best job, ever
Thanks to a grant from the National Association of Science Writers, the New England Science Writers has made their Jan. 19 presentation on health & science blogging freely available online. The panel featured: Moderator Alison Bass, http://alison-bass.blogspot.com Daniel Carlat: The Carlat Psychiatry Blog: Promoting honesty in medical education, http://carlatpsychiatry.blogspot.com Ivan Oransky: Embargo Watch: Keeping an…
-
Bill to help Canadian companies ship generics has uncertain future
From Nature Medicine. Published online 7 March 2011. Backed by nongovernmental organizations and the generics industry, the left-of-center New Democratic Party has championed a bill that set out to improve Canada’s Access to Medicines Regime (CAMR), a law that enables drug manufacturers in the country to make generic medications for shipment to developing countries to treat illnesses…
-
Cancer drugs should add months, not weeks, say experts
From Nature Medicine. Published online 7 January 2011. In the last decade, the world’s drug regulatory agencies have approved dozens of new anticancer therapies for everything from lung carcinoma to skin melanoma. Some of these new drugs add months to a patient’s life. But others may offer only an extra week or two, on average,…